Biolasco Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 11, 2020 at 10:35 pm
Share
BioLASCO Taiwan Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 57.970 million compared to TWD 140.644 million a year ago. Operating income was TWD 14.303 million compared to TWD 38.297 million a year ago. Net income was TWD 11.235 million compared to TWD 30.428 million a year ago. Basic earnings per share was TWD 0.44 compared to TWD 1.19 a year ago. For the half year, sales was TWD 149.102 million compared to TWD 222.596 million a year ago. Operating income was TWD 37.077 million compared to TWD 44.236 million a year ago. Net income was TWD 28.980 million compared to TWD 34.155 million a year ago. Basic earnings per share was TWD 1.13 compared to TWD 1.39 a year ago.
BioLASCO Taiwan Co., Ltd. is a Taiwan-based company mainly engaged in the production of Specific Pathogen Free (SPF) laboratory animals and the high-value special-mode experimental animals, as well as the introduction and production of highly-applicable disease-mode animals. The company also provides equipment related to feeding, supplies and testing platform, life science research and pharmaceutical development services.